Assessment of high-sensitivity C-reactive protein as a marker of airway inflammation in asthma

Annals of Allergy, Asthma and Immunology

Volumn 104, Issue 6, 2010, Pages 485-489

  Ramirez, Daniel ^a   Patel, Parag ^a   Casillas, Adrian ^a   Cotelingam, James ^a   Boggs, Peter ^a   Bahna, Sami L ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; NITRIC OXIDE;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SPIROMETRY; WHEEZING;

ADOLESCENT; ADULT; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; C-REACTIVE PROTEIN; CHILD; FORCED EXPIRATORY VOLUME; HUMANS; MIDDLE AGED; NITRIC OXIDE;

EID: 77953169087     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.04.004     Document Type: Article

References (36)

1. Pepys M.B., and Baltz M.L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 34 (1983) 141-212
2. Tracy R.P., Lemaitre R.N., Psaty B.M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17 (1997) 1121-1127
3. Nabipour I., Vahdat K., Jafari S.M., et al. Elevated high sensitivity C-reactive protein is associated with type 2 diabetes mellitus: the Persian Gulf Healthy Heart Study. Endocr J 55 (2008) 717-722
4. Dahl M., Vestbo J., Lange P., Bojesen S.E., Tybjaerg-Hansen A., and Nordestgaard B.G. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 (2007) 250-255
5. Kony S., Zureik M., Driss F., Neukirch C., Leynaert B., and Neukirch F. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 59 (2004) 892-896
6. Olafsdottir I.S., Gislason T., Thjodleifsson B., et al. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 60 (2005) 451-454
7. Expert Panel Report 3 (EPR-3). Guidelines for the Diagnosis and Management of Asthma: summary report 2007. J Allergy Clin Immunol 120 (2007) S94-S138
8. Ridker P.M. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation 108 (2003) 2292-2297
9. Jousilahti P., Salomaa V., Hakala K., Rasi V., Vahtera E., and Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 89 (2002) 381-385
10. Fujita M., Ueki S., Ito W., et al. C-reactive protein levels in the serum of asthmatic patients. Ann Allergy Asthma Immunol 99 (2007) 48-53
11. Qian F.H., Zhang Q., Zhou L.F., et al. High-sensitivity C-reactive protein: a predicative marker in severe asthma. Respirology 13 (2008) 664-669
12. Zietkowski Z., Tomasiak-Lozowska M.M., Skiepko R., Mroczko B., Szmitkowski M., and Bodzenta-Lukaszyk A. High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma. Respir Med 103 (2009) 379-385
13. Allam M.H., Said A.F., El Samie Omran A.A., Abd El-Reheim D.M., and Kasem A.H. High sensitivity C-reactive protein: its correlation with sputum cell counts in bronchial asthma. Respir Med 103 (2009) 1878-1884
14. Alving K., Weitzberg E., and Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 6 (1993) 1368-1370
15. Takemura M., Matsumoto H., Niimi A., et al. High sensitivity C-reactive protein in asthma. Eur Respir J 27 (2006) 908-912
16. Kasayama S., Tanemura M., Koga M., Fujita K., Yamamoto H., and Miyatake A. Asthma is an independent risk for elevation of plasma C-reactive protein levels. Clin Chim Acta 399 (2009) 79-82
17. Araujo J.P., Lourenco P., Azevedo A., et al. Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail 15 (2009) 256-266
18. El-Sharrawy E.A., El-Hakim I.E., and Sameeh E. Attenuation of C-reactive protein increases after exodontia by tramadol and ibuprofen. Anesth Prog 53 (2006) 78-82
19. Arsenault B.J., Earnest C.P., Despres J.P., Blair S.N., and Church T.S. Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use. Eur J Clin Nutr 63 (2009) 1419-1424
20. Primatesta P., Falaschetti E., and Poulter N.R. Influence of hormone replacement therapy on C-reactive protein: population-based data. J Cardiovasc Risk 10 (2003) 57-60
21. Hwang H.S., Kwon J.Y., Kim M.A., Park Y.W., and Kim Y.H. Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 98 (2007) 105-109
22. Westhuyzen J., and Healy H. Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease. Ann Clin Lab Sci 30 (2000) 133-143
23. Kerner A., Avizohar O., Sella R., et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 25 (2005) 193-197
24. Hind C.R., Savage C.O., Winearls C.G., and Pepys M.B. Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration. Br Med J (Clin Res Ed) 288 (1984) 1027-1030
25. Sennels H., Sorensen S., Ostergaard M., et al. Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. Scand J Rheumatol 37 (2008) 241-247
26. Sergeant A., Makrygeorgou A., Chan W.C., Thorrat A., and Burden D. C-reactive protein in psoriasis. Br J Dermatol 158 (2008) 417-419
27. Sindic C.J., Collet-Cassart D., Depre A., Laterre E.C., and Masson P.L. C-reactive protein in serum and cerebrospinal fluid in various neurological disorders. Apparent local consumption during bacterial meningitis. J Neurol Sci 63 (1984) 339-344
28. Melbye H., Hvidsten D., Holm A., Nordbo S.A., and Brox J. The course of C-reactive protein response in untreated upper respiratory tract infection. Br J Gen Pract 54 (2004) 653-658
29. Kharitonov S.A., Yates D., and Barnes P.J. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 8 (1995) 295-297
30. Maziak W., Loukides S., Culpitt S., Sullivan P., Kharitonov S.A., and Barnes P.J. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 998-1002
31. Santos A.C., Lopes C., Guimaraes J.T., and Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int J Obes 29 (2005) 1452-1456
32. De Winter-de Groot K.M., Van der Ent C.K., Prins I., Tersmette J.M., and Uiterwaal C.S. Exhaled nitric oxide: the missing link between asthma and obesity?. J Allergy Clin Immunol 115 (2005) 419-420
33. Madsen C., Nafstad P., Eikvar L., Schwarze P.E., Ronningen K.S., and Haaheim L.L. Association between tobacco smoke exposure and levels of C-reactive protein in the Oslo II Study. Eur J Epidemiol 22 (2007) 311-317
34. Kharitonov S.A., Robbins R.A., Yates D., Keatings V., and Barnes P.J. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 152 (1995) 609-612
35. Kallio R., Surcel H.M., Bloigu A., and Syrjala H. C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 36 (2000) 889-894
36. Liu C.Y., Wang C.H., Chen T.C., Lin H.C., Yu C.T., and Kuo H.P. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer 78 (1998) 534-541